Compounds > 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and isoflurane

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with isoflurane in 1 studies

Compound Research Comparison

Studies
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Trials
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Recent Studies (post-2010)
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Studies
(isoflurane)		Trials
(isoflurane)		Recent Studies (post-2010) (isoflurane)
33040339,7232,1172,666

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cremer, M; Kosinski, CM; Langen, KJ; Meyer, PT; Salber, D; Schaefer, WM; Schiefer, J1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and isoflurane

ArticleYear
Cerebral kinetics of the dopamine D(2) receptor ligand [(123)I]IBZM in mice.
    Nuclear medicine and biology, 2008, Volume: 35, Issue:4

    Topics: Anesthesia; Anesthetics, Inhalation; Animals; Autoradiography; Benzamides; Brain; Isoflurane; Kinetics; Mice; Models, Animal; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2008